CI Investments Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,424
Closed -$131K 727
2025
Q3
$131K Sell
2,424
-1,210
-33% -$69.2K ﹤0.01% 814
2025
Q2
$200K Sell
3,634
-32
-0.9% -$1.88K ﹤0.01% 710
2025
Q1
$259K Sell
3,666
-1,910
-34% -$128K ﹤0.01% 662
2024
Q4
$367K Buy
5,576
+832
+18% +$55.7K ﹤0.01% 576
2024
Q3
$333K Sell
4,744
-217
-4% -$18.1K ﹤0.01% 555
2024
Q2
$408K Sell
4,961
-431
-8% -$35.9K ﹤0.01% 505
2024
Q1
$471K Buy
5,392
+2,298
+74% +$206K ﹤0.01% 491
2023
Q4
$298K Sell
3,094
-515
-14% -$45.6K ﹤0.01% 534
2023
Q3
$319K Sell
3,609
-489
-12% -$43.5K ﹤0.01% 520
2023
Q2
$355K Sell
4,098
-323
-7% -$30.4K ﹤0.01% 532
2023
Q1
$430K Buy
4,421
+1,334
+43% +$138K ﹤0.01% 460
2022
Q4
$319K Sell
3,087
-129
-4% -$12.1K ﹤0.01% 521
2022
Q3
$273K Buy
3,216
+221
+7% +$19.7K ﹤0.01% 524
2022
Q2
$248K Sell
2,995
-783
-21% -$62.3K ﹤0.01% 571
2022
Q1
$291K Sell
3,778
-378
-9% -$31.6K ﹤0.01% 635
2021
Q4
$367K Buy
4,156
+167
+4% +$13.8K ﹤0.01% 653
2021
Q3
$308K Buy
3,989
+1,076
+37% +$84.9K ﹤0.01% 672
2021
Q2
$243K Sell
2,913
-1,203
-29% -$95.4K ﹤0.01% 712
2021
Q1
$311K Buy
4,116
+1,193
+41% +$97.5K ﹤0.01% 612
2020
Q4
$256K Buy
2,923
+1,064
+57% +$84.4K ﹤0.01% 629
2020
Q3
$141K Buy
1,859
+468
+34% +$47.4K ﹤0.01% 616
2020
Q2
$172K Buy
1,391
+230
+20% +$22.9K ﹤0.01% 538
2020
Q1
$98K Buy
1,161
+381
+49% +$32.8K ﹤0.01% 525
2019
Q4
$66K Buy
780
+698
+851% +$52.7K ﹤0.01% 589
2019
Q3
$6K Buy
+82
New +$6.32K ﹤0.01% 582
2016
Q3
Sell
-28,500
Closed -$2.22M 216
2016
Q2
$2.22M Hold
28,500
0.03% 152
2016
Q1
$2.35M Buy
+28,500
New +$2.32M 0.03% 141
2015
Q4
Sell
-141,000
Closed -$14.8M 182
2015
Q3
$14.8M Sell
141,000
-19,000
-12% -$2.54M 0.19% 96
2015
Q2
$21.9M Buy
160,000
+13,100
+9% +$1.62M 0.24% 96
2015
Q1
$18.3M Buy
+146,900
New +$15.6M 0.19% 91

Other funds holding BMRN